{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T03:45:41Z","timestamp":1787888741430,"version":"build-2784847793"},"reference-count":25,"publisher":"Associa\u00e7\u00e3o de Medicina Intensiva Brasileira","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,2]]},"DOI":"10.62675\/2965-2774.20260197","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T15:51:24Z","timestamp":1770133884000},"source":"Crossref","is-referenced-by-count":2,"title":["Effect of norepinephrine versus vasopressin weaning on incidence of hypotension in septic shock patients: a systematic review and meta-analysis"],"prefix":"10.62675","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7138-2091","authenticated-orcid":false,"given":"C\u00e1ssio","family":"Mallmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5388-9163","authenticated-orcid":false,"given":"Lucas Oliveira J.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4699-7166","authenticated-orcid":false,"given":"Michele Salibe de","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9062-9983","authenticated-orcid":false,"given":"Thiz\u00e1 Maria Bianchi","family":"Galiotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2539-4256","authenticated-orcid":false,"given":"Wagner Luis","family":"Nedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6631-7260","authenticated-orcid":false,"given":"Rafael Barberena","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"49293","reference":[{"issue":"11","key":"key20260203155118_B1","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","unstructured":"1 Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181-247.","journal-title":"Intensive Care Med"},{"issue":"9","key":"key20260203155118_B2","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell","year":"2008","unstructured":"2 Russell JA, Walley KR, Singer J, Gordon AC, H\u00e9bert PC, Cooper DJ, et al.; VASST Investigators. vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358(9):877-87.","journal-title":"N Engl J Med"},{"issue":"2","key":"key20260203155118_B3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/CCM.0000000000006135","article-title":"Surviving Sepsis Campaign Research Priorities 2023","volume":"52","author":"De Backer","year":"2024","unstructured":"3 De Backer D, Deutschman CS, Hellman J, Myatra SN, Ostermann M, Prescott HC, et al.; Surviving Sepsis Campaign Research Committee. Surviving Sepsis Campaign Research Priorities 2023. Crit Care Med. 2024;52(2):268-96.","journal-title":"Crit Care Med"},{"issue":"1","key":"key20260203155118_B4","doi-asserted-by":"crossref","first-page":"16680","DOI":"10.1038\/s41598-021-96322-7","article-title":"The order of vasopressor discontinuation and incidence of hypotension: a retrospective cohort analysis","volume":"11","author":"Song","year":"2021","unstructured":"4 Song X, Liu X, Evans KD, Frank RD, Barreto EF, Dong Y, et al. The order of vasopressor discontinuation and incidence of hypotension: a retrospective cohort analysis. Sci Rep. 2021;11(1):16680.","journal-title":"Sci Rep"},{"issue":"1","key":"key20260203155118_B5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13054-018-2034-9","article-title":"Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS)","volume":"22","author":"Jeon","year":"2018","unstructured":"5 Jeon K, Song JU, Chung CR, Yang JH, Suh GY. Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS). Crit Care. 2018;22(1):131.","journal-title":"Crit Care"},{"issue":"5","key":"key20260203155118_B6","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/01.CIR.95.5.1122","article-title":"Vasopressin deficiency contributes to the vasodilation of septic shock","volume":"95","author":"Landry","year":"1997","unstructured":"6 Landry DW, Levin HR, Gallant EM, Ashton RC Jr, Seo S, D\u2019Alessandro D, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997;95(5):1122-5.","journal-title":"Circulation"},{"issue":"3","key":"key20260203155118_B7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/jac5.1079","article-title":"Perceptions regarding vasopressin use and practices in septic shock, and cost containment strategies","volume":"2","author":"Hammond","year":"2019","unstructured":"7 Hammond DA, Rech MA, Daley MJ, Devlin JW, Hodge EK, Kooda KJ, et al. Perceptions regarding vasopressin use and practices in septic shock, and cost containment strategies. J Am Coll Clin Pharm. 2019;2(3):257-67.","journal-title":"J Am Coll Clin Pharm"},{"key":"key20260203155118_B8","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","unstructured":"8 Sterne JA, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"key":"key20260203155118_B9","author":"Wells","year":"2004","unstructured":"9 Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta analysis. 2004. [cited 2023June 13]. Available from: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp","journal-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta analysis"},{"issue":"1","key":"key20260203155118_B10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","unstructured":"10 Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14(1):135.","journal-title":"BMC Med Res Methodol"},{"issue":"11","key":"key20260203155118_B11","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","unstructured":"11 Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-58.","journal-title":"Stat Med"},{"issue":"7454","key":"key20260203155118_B12","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","unstructured":"12 Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al.; GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ. 2004;328(7454):1490.","journal-title":"BMJ"},{"issue":"4","key":"key20260203155118_B13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","unstructured":"13 Balshem H, Helfand M, Sch\u00fcnemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401-6.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"key20260203155118_B14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/ebmed-2017-110668","article-title":"Rating the certainty in evidence in the absence of a single estimate of effect","volume":"22","author":"Murad","year":"2017","unstructured":"14 Murad MH, Mustafa RA, Sch\u00fcnemann HJ, Sultan S, Santesso N. Rating the certainty in evidence in the absence of a single estimate of effect. Evid Based Med. 2017;22(3):85-7.","journal-title":"Evid Based Med"},{"issue":"2","key":"key20260203155118_B15","doi-asserted-by":"crossref","first-page":"362.e7","DOI":"10.1016\/j.jcrc.2009.10.005","article-title":"Discontinuation of vasopressin before norepinephrine increases the incidence of hypotension in patients recovering from septic shock: a retrospective cohort study","volume":"25","author":"Bauer","year":"2010","unstructured":"15 Bauer SR, Aloi JJ, Ahrens CL, Yeh JY, Culver DA, Reddy AJ. Discontinuation of vasopressin before norepinephrine increases the incidence of hypotension in patients recovering from septic shock: a retrospective cohort study. J Crit Care. 2010;25(2):362.e7-11.","journal-title":"J Crit Care"},{"issue":"10","key":"key20260203155118_B16","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1177\/0885066617714209","article-title":"Discontinuation of vasopressin before norepinephrine in the recovery phase of septic shock","volume":"34","author":"Hammond","year":"2019","unstructured":"16 Hammond DA, McCain K, Painter JT, Clem OA, Cullen J, Brotherton AL, et al. Discontinuation of vasopressin before norepinephrine in the recovery phase of septic shock. J Intensive Care Med. 2019;34(10):805-10.","journal-title":"J Intensive Care Med"},{"issue":"9","key":"key20260203155118_B17","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1177\/0885066617716396","article-title":"Hemodynamic instability secondary to vasopressin withdrawal in septic shock","volume":"34","author":"Bissell","year":"2019","unstructured":"17 Bissell BD, Magee C, Moran P, Bastin ML, Flannery AH. Hemodynamic instability secondary to vasopressin withdrawal in septic shock. J Intensive Care Med. 2019;34(9):761-5.","journal-title":"J Intensive Care Med"},{"issue":"3","key":"key20260203155118_B18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/phar.2082","article-title":"Hypotension risk based on vasoactive agent discontinuation order in patients in the recovery phase of septic shock","volume":"38","author":"Sacha","year":"2018","unstructured":"18 Sacha GL, Lam SW, Duggal A, Torbic H, Reddy AJ, Bauer SR. Hypotension risk based on vasoactive agent discontinuation order in patients in the recovery phase of septic shock. Pharmacotherapy. 2018;38(3):319-26.","journal-title":"Pharmacotherapy"},{"issue":"8","key":"key20260203155118_B19","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1177\/1060028018765187","article-title":"Evaluating vasopressor discontinuation strategies in patients with septic shock on concomitant norepinephrine and vasopressin infusions","volume":"52","author":"Musallam","year":"2018","unstructured":"19 Musallam N, Altshuler D, Merchan C, Zakhary B, Aberle C, Papadopoulos J. Evaluating vasopressor discontinuation strategies in patients with septic shock on concomitant norepinephrine and vasopressin infusions. Ann Pharmacother. 2018;52(8):733-9.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"key20260203155118_B20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/0018578718817469","article-title":"Impact of the sequence of norepinephrine and vasopressin discontinuation in patients recovering from septic shock","volume":"55","author":"Bredhold","year":"2020","unstructured":"20 Bredhold BE, Winters SD, Callison JC Jr, Heidel RE, Allen LM, Hamilton LA. Impact of the sequence of norepinephrine and vasopressin discontinuation in patients recovering from septic shock. Hosp Pharm. 2020;55(1):26-31.","journal-title":"Hosp Pharm"},{"issue":"6","key":"key20260203155118_B21","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1177\/08971900211015080","article-title":"Vasopressor discontinuation order in septic shock with reduced left ventricular function","volume":"35","author":"Taylor","year":"2022","unstructured":"21 Taylor A, Jones T, Forehand CC, Smith SE, Dykes H, Newsome AS. Vasopressor discontinuation order in septic shock with reduced left ventricular function. J Pharm Pract. 2022;35(6):879-85.","journal-title":"J Pharm Pract"},{"issue":"10","key":"key20260203155118_B22","doi-asserted-by":"crossref","first-page":"502147","DOI":"10.1016\/j.medin.2025.502147","article-title":"Reduction of norepinephrine versus vasopressin in the stabilization phase of septic shock: RENOVA clinical trial","volume":"49","author":"Mallmann","year":"2025","unstructured":"22 Mallmann C, Galiotto TM, de Oliveira MS, Moraes RB. Reduction of norepinephrine versus vasopressin in the stabilization phase of septic shock: RENOVA clinical trial. Med Intensiva (Engl Ed). 2025;49(10):502147.","journal-title":"Med Intensiva (Engl Ed)"},{"issue":"1","key":"key20260203155118_B23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/0018578719867646","article-title":"Analysis of vasopressor discontinuation and the incidence of rebound hypotension in patients with septic shock","volume":"56","author":"Buckley","year":"2021","unstructured":"23 Buckley CT, Turner B, Walsh D, Garrett MJ, Ooka VN. Analysis of vasopressor discontinuation and the incidence of rebound hypotension in patients with septic shock. Hosp Pharm. 2021;56(1):47-53.","journal-title":"Hosp Pharm"},{"issue":"18","key":"key20260203155118_B24","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.4528","article-title":"Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: a systematic review and meta-analysis","volume":"319","author":"McIntyre","year":"2018","unstructured":"24 McIntyre WF, Um KJ, Alhazzani W, Lengyel AP, Hajjar L, Gordon AC, et al. Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: a systematic review and meta-analysis. JAMA. 2018;319(18):1889-900.","journal-title":"JAMA"},{"issue":"1","key":"key20260203155118_B25","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/CCM.0000000000003471","article-title":"Renal outcomes of vasopressin and its analogs in distributive shock: a systematic review and meta-analysis of randomized trials","volume":"47","author":"Nedel","year":"2019","unstructured":"25 Nedel WL, Rech TH, Ribeiro RA, Pellegrini JA, Moraes RB. Renal outcomes of vasopressin and its analogs in distributive shock: a systematic review and meta-analysis of randomized trials. Crit Care Med. 2019;47(1):e44-51.","journal-title":"Crit Care Med"}],"container-title":["Critical Care Science"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T15:51:27Z","timestamp":1770133887000},"score":1,"resource":{"primary":{"URL":"https:\/\/criticalcarescience.org\/article\/effect-of-norepinephrine-versus-vasopressin-weaning-on-incidence-of-hypotension-in-septic-shock-patients-a-systematic-review-and-meta-analysis\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":25,"alternative-id":["10.62675\/2965-2774.20260197"],"URL":"https:\/\/doi.org\/10.62675\/2965-2774.20260197","relation":{},"ISSN":["2965-2774"],"issn-type":[{"value":"2965-2774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e20260197"}}